|
|
|
National Stock Number:
6505-01-618-5356
Federal Supply Class:
6505
National Item Identification Number:
016185356
Description:
EMTRICITABINE AND TENOFOVIR TABL
|
Manufacturer Information:
| 449511 | 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA | | 6505NCM139136 | 64616 | DEFENSE MEDICAL STANDARDIZATION BOARD | | NDC61958-0701-01 | 0SFJ8 | GILEAD SCIENCES INC | | NDC51407-0112-30 | 1HT23 | GOLDEN STATE MEDICAL SUPPLY, INC. | | NDC00093-7704-56 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. | | NDC42291-0439-30 | 4QGW8 | AVKARE LLC | | NDC76282-0677-30 | 6GFC4 | EXELAN PHARMACEUTICALS INC |
|
Techincal Specification:
| PART NAME ASSIGNED BY CONTROLLING AGENCY | EMTRICITABINE/TENFOVIR (200MG/300MG) TABS 30S | | PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE | | SPECIAL FEATURES | 200MG EMTRICITABINE AND 300MG OF TENOFOVIR DISOPROXIL FUMARATE; 30 TABLETS PER BOTTLE; TAKEN ORALLY; COMBINATION OF EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE IS INDICATED IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS (SUCH AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OR PROTEASE INHIBITORS) FOR THE TREATMENT OF HIV-1 INFECTION IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER; ALSO APPROVED FOR USE IN COMBINATION WITH SAFER SEX PRACTICES FOR PRE-EXPOSURE PROPHYLAXIS (PREP), TO REDUCE THE RISK OF SEXUALLY ACQUIRED HIV-1 INFECTION IN ADULTS AT HIGH RISK |
|